PMC Links for Gene (Select 80312) - PMC

Result Filters

Links from Gene

Items: 1 to 20 of 143

<< First< Prev

Page of 8

Next >Last >>

Select item 109136961.

TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy

Ji Ren, Xiuying Chen, Jing Li, Yuxin Zan, Shan Wang, Yujie Tan, Yan Ding

Epigenetics. 2024; 19(1): 2323751. Published online 2024 Mar 3. doi: 10.1080/15592294.2024.2323751

PMCID:: PMC10913696

Abstract Article PDF–5.9M

Select item 103995302.

Functional polymorphisms of the TET1 gene increase the risk of neuroblastoma in Chinese children

Jiaming Chang, Lei Lin, Chunlei Zhou, Xinxin Zhang, Tianyou Yang, Haiyan Wu, Yan Zou, Jing He

J Cell Mol Med. 2023 Aug; 27(15): 2239–2248. Published online 2023 Jun 22. doi: 10.1111/jcmm.17820

PMCID:: PMC10399530

Abstract Article PDF–1.6M

Select item 101819353.

Hypoxia switches TET1 from being tumor-suppressive to oncogenic

Qi Yang, Hui Dang, Jiaxin Liu, Xingye Wang, Jingyuan Wang, Xinhui Lan, Meiju Ji, Mingzhao Xing, Peng Hou

Oncogene. 2023; 42(20): 1634–1648. Published online 2023 Apr 5. doi: 10.1038/s41388-023-02659-w

PMCID:: PMC10181935

Abstract Article PDF–5.3M

Select item 89918514.

TET1 mutations as a predictive biomarker for immune checkpoint inhibitors in colon adenocarcinoma

Tianzhu Qiu, Xiaoxuan Wang, Furong Du, Xiangjing Hu, Fujun Sun, Chao Song, Jie Zhao

World J Surg Oncol. 2022; 20: 115. Published online 2022 Apr 8. doi: 10.1186/s12957-022-02581-7

PMCID:: PMC8991851

Abstract Article PDF–2.1M

Select item 86308815.

Tracing TET1 expression in prostate cancer: discovery of malignant cells with a distinct oncogenic signature

U. Schagdarsurengin, C. Luo, H. Slanina, D. Sheridan, S. Füssel, N. Böğürcü-Seidel, S. Gattenloehner, G. B. Baretton, L. C. Hofbauer, F. Wagenlehner, T. Dansranjav

Clin Epigenetics. 2021; 13: 211. Published online 2021 Nov 29. doi: 10.1186/s13148-021-01201-7

PMCID:: PMC8630881

Abstract Article PDF–11M

Select item 85657576.

Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma

Nien-Tzu Liu, Cherng-Lih Perng, Yu-Ching Chou, Pi-Shao Ko, Yi-Jia Lin, Yu-Chun Lin, Cheng-Chang Chang, Yu-Chi Wang, Hung-Sheng Shang, Tai-Kuang Chao

PLoS One. 2021; 16(11): e0259330. Published online 2021 Nov 3. doi: 10.1371/journal.pone.0259330

PMCID:: PMC8565757

Abstract Article PDF–2.2M

Select item 82532817.

TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma

Kiyokazu Shirai, Genta Nagae, Motoaki Seki, Yotaro Kudo, Asuka Kamio, Akimasa Hayashi, Atsushi Okabe, Satoshi Ota, Shuichi Tsutsumi, Takanori Fujita, Shogo Yamamoto, Ryo Nakaki, Yasuharu Kanki, Tsuyoshi Osawa, Yutaka Midorikawa, Keisuke Tateishi, Masao Ichinose, Hiroyuki Aburatani

Cancer Sci. 2021 Jul; 112(7): 2855–2869. Published online 2021 May 10. doi: 10.1111/cas.14897

PMCID:: PMC8253281

Abstract Article PDF–2.4M

Select item 79491108.

Single-molecule multiplexed profiling of protein–DNA complexes using magnetic tweezers

Lin Liang, Zeyu Wang, Lihua Qu, Wei Huang, Shuang Guo, Xiangchen Guan, Wei Zhang, Fuping Sun, Hongrui Yuan, Huiru Zou, Haitao Liu, Zhongbo Yu

J Biol Chem. 2021 Jan-Jun; 296: 100327. Published online 2021 Jan 23. doi: 10.1016/j.jbc.2021.100327

PMCID:: PMC7949110

Abstract Article PDF–3.7M

Select item 78555009.

TET1 promotes malignant progression of cholangiocarcinoma with IDH1 wild-type

Xuewei Bai, Hongyu Zhang, Yamei Zhou, Katsuya Nagaoka, Jialin Meng, Chengcheng Ji, Dan Liu, Xianghui Dong, Kevin Cao, Joud Mulla, Zhixiang Cheng, William Mueller, Amalia Bay, Grace Hildebrand, Shaolei Lu, Joselynn Wallace, Jack R. Wands, Bei Sun, Chiung-Kuei Huang

Hepatology. Author manuscript; available in PMC 2022 May 1.

Published in final edited form as: Hepatology. 2021 May; 73(5): 1747–1763. doi: 10.1002/hep.31486

PMCID:: PMC7855500

Abstract Article PDF–1.2M

Select item 783873510.

Inhibition of Migration and Invasion by Tet-1 Overexpression in Human Lung Carcinoma H460 Cells

Si Jun Park, Bo Ram Lee, Hyeng-Soo Kim, Young Rae Ji, Yong Hun Sung, Kwang ShikChoi, Hum Dai Park, Sung-Hyun Kim, Myoung Ok Kim, Zae Young Ryoo

Oncol Res. 2016; 23(3): 89–98. Published online 2016 Feb 29. doi: 10.3727/096504015X14496932933539

PMCID:: PMC7838735

Abstract Article PDF–9.6M

Select item 765925211.

Loss of 5‐hydroxymethylcytosine is accompanied with malignant cellular transformation

Yotaro Kudo, Keisuke Tateishi, Keisuke Yamamoto, Shinzo Yamamoto, Yoshinari Asaoka, Hideaki Ijichi, Genta Nagae, Haruhiko Yoshida, Hiroyuki Aburatani, Kazuhiko Koike

Cancer Sci. 2012 Apr; 103(4): 670–676. Published online 2012 Feb 27. doi: 10.1111/j.1349-7006.2012.02213.x

PMCID:: PMC7659252

Abstract Article PDF–605K

Select item 764275712.

Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma

Sebastian Stasik, Tareq A. Juratli, Andreas Petzold, Sven Richter, Amir Zolal, Gabriele Schackert, Andreas Dahl, Dietmar Krex, Christian Thiede

Neoplasia. 2020 Dec; 22(12): 800–808. Published online 2020 Nov 2. doi: 10.1016/j.neo.2020.10.010

PMCID:: PMC7642757

Abstract Article PDF–2.3M

Select item 759885713.

Prognostic role of high TET1 expression in patients with solid tumors: A meta-analysis

Qiwei Ke, Kai Wang, Min Fan, Mengchao Li, Guanghua Luo, Daming Wang

Medicine (Baltimore) 2020 Oct 30; 99(44): e22863. Published online 2020 Oct 30. doi: 10.1097/MD.0000000000022863

PMCID:: PMC7598857

Abstract Article PDF–887K

Select item 726436014.

Measuring Cancer Hallmark Mediation of the TET1 Glioma Survival Effect with Linked Neural-Network Based Mediation Experiments

Thomas Luechtefeld, Nole Lin, Channing Paller, Katherine Kuhns, John J. Laterra, Joseph P. Bressler

Sci Rep. 2020; 10: 8886. Published online 2020 Jun 1. doi: 10.1038/s41598-020-65369-3

PMCID:: PMC7264360

Abstract Article PDF–2.1M

Select item 679842915.

Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers

Hao-Xiang Wu, Yan-Xing Chen, Zi-Xian Wang, Qi Zhao, Ming-Ming He, Ying-Nan Wang, Feng Wang, Rui-Hua Xu

J Immunother Cancer. 2019; 7: 264. Published online 2019 Oct 17. doi: 10.1186/s40425-019-0737-3

Correction in:: J Immunother Cancer. 2020; 8(1): e0737-3corr1.

PMCID:: PMC6798429

Abstract Article PDF–1.8M

Select item 677538616.

Ten-Eleven Translocation (TET) Enzymes Modulate the Activation of Dendritic Cells in Allergic Rhinitis

Hang Li, Tong Lu, Wei Sun, Renqiang Ma, Hua Zhong, Yi Wei, Dehua Chen, Yihui Wen, Chris Carlsten, Weiping Wen

Front Immunol. 2019; 10: 2271. Published online 2019 Sep 26. doi: 10.3389/fimmu.2019.02271

PMCID:: PMC6775386

Abstract Article PDF–1.5M

Select item 668831817.

TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells

Jian Wu, Hongzhe Li, Minmin Shi, Youwei Zhu, Yang Ma, Yiming Zhong, Cheng Xiong, Hao Chen, Chenghong Peng

J Exp Clin Cancer Res. 2019; 38: 348. Published online 2019 Aug 9. doi: 10.1186/s13046-019-1334-5

PMCID:: PMC6688318

Abstract Article PDF–5.5M

Select item 658396218.

TET1 is an important transcriptional activator of TNFα expression in macrophages

Fangfang Sun, Irene Abreu-Rodriguez, Shuang Ye, Steffen Gay, Oliver Distler, Michel Neidhart, Emmanuel Karouzakis

PLoS One. 2019; 14(6): e0218551. Published online 2019 Jun 19. doi: 10.1371/journal.pone.0218551

PMCID:: PMC6583962

Abstract Article PDF–2.0M

Select item 657965519.

TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target

Lin-Yu Chen, Rui-Lan Huang, Michael W.Y. Chan, Pearlly S. Yan, Tien-Shuo Huang, Ren-Chin Wu, Yohan Suryo Rahmanto, Po-Hsuan Su, Yu-Chun Weng, Jian-Liang Chou, Tai-Kuang Chao, Yu-Chi Wang, Ie-Ming Shih, Hung-Cheng Lai

J Pathol. Author manuscript; available in PMC 2020 Jul 1.

Published in final edited form as: J Pathol. 2019 Jul; 248(3): 363–376. Published online 2019 Apr 23. doi: 10.1002/path.5266